The global empty capsules market size was estimated to be USD 3.46 billion in 2023 and is expected to reach at USD 9.72 billion by 2034 with a CAGR of 9.85% during the forecast period 2024-2034. Increasing demand for nutraceuticals, growing awareness regarding the benefits of capsules, surge in the popularity of capsules compared to alternative drug delivery methods, rising collaborations within empty capsule suppliers & gelatine manufacturers, increasing geriatric population driving a higher demand for a wide range of therapeutic medications & dietary supplements to improve overall health outcomes, growing developments in the field of capsule delivery technologies, and surge in approval of new capsules are some of the key factors boosting the market growth.
Surge in approval of new capsules is predicted to boost the market growth during the forecast period. Empty capsules are frequently employed for the containment of powders, medicines, and herbal substances. In comparison to tablets, capsules are more convenient to ingest. Pharmaceutical companies utilize them to formulate a wide range of therapeutic drugs. For instance, in February 2022, CapsCanada, a subsidiary of Lyfe Group, has obtained approval for a liquid-filled aspirin capsule. This product utilizes the PLxGuard drug delivery platform, designed to deliver medications within the gastrointestinal tract.
By type, gelatin capsules was the highest revenue-grossing segment in the global empty capsules market in 2023 owing to the affordability & ready availability of gelatine for production, increasing adoption of capsule formulation, surge in the protein content of gelatin capsules, growing advancements in capsule delivery technologies, and rising launch of new products. For instance, in May 2022, Lonza has broadened its Capsugel product range by introducing a white hard gelatin capsule that is free from titanium dioxide (TiO2). This move aligns with the changing preferences of its customers, who seek compliance with the new TiO2-free regulations for food products in the European Union. Additionally, non-gelatin capsules is predicted to grow at fastest CAGR during the forecast period owing to the rising demand of HPMC capsules due to their low moisture content, resistance to bacterial growth, & the absence of a need for preservatives during production and increasing adoption of vegetarian lifestyle with dietary needs.
By functionality, immediate release was the highest revenue-grossing segment in the global empty capsules market in 2023 owing to the growing demand for these capsules for manufacturing drug preparations such as antacids, antibacterial antibiotics and increasing introduction of new products. For instance, in November 2022, Lonza has introduced a novel capsule solution called Enprotect, specifically designed to enhance the delivery of acid-sensitive Active Pharmaceutical Ingredients (APIs) when ingested. This product launch has contributed to the expansion of the company's product portfolio. Additionally, sustained release is predicted to grow at fastest CAGR during the forecast period owing to the rising focus on development of advanced capsules and surge in research & development activities.
By application, cardiovascular therapy drugs was the highest revenue-grossing segment in the global empty capsules market in 2023 owing to rising prevalence of cardiovascular diseases, surge in approvals by regulatory bodies, and growing need for empty capsules to conceal the taste of cardiac therapy medications, effectively preventing patients from experiencing nausea. Additionally, dietary supplements is predicted to grow at fastest CAGR during the forecast period owing to the availability & growing demand of dietary supplements and surge in mergers & acquisitions by market players. For instance, in December 2022, Vantage Nutrition LLC, a subsidiary of the ACG Group, has acquired AquaCap, an asset of Nestle Health Science, which is based in Philadelphia. The primary objective of this acquisition is to increase Vantage Nutrition's presence and enhance its manufacturing capabilities.
By end-user, pharmaceutical companies was the highest revenue-grossing segment in the global empty capsules market in 2023 owing to surge in prevalence of various diseases, increasing focus on development of advanced capsules with superior quality & dissolution properties, growing support & incentives provided by the government for the manufacturing of various pharmaceutical products, and rising mergers & acquisitions within market players. For instance, in March 2023, VANTAGE NUTRITION, a subsidiary of ACG, has successfully acquired ComboCap, Inc. in the United States and BioCap in South Africa. This strategic move is part of their plan to broaden their technological capabilities and expand their presence in North America and worldwide. Additionally, nutraceutical industry is predicted to grow at fastest CAGR during the forecast period owing to the growing preference of nutraceuticals products by population, rising prevalence of chronic conditions such as cardiovascular disease & diabetes due to the adoption of sedentary lifestyle, and surge in demand for dietary supplements.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing preference for capsule-based nutraceutical formulations, rising prevalence of chronic diseases, surge in research & development activities, and growing launch of new products. For instance, in February 2023, Vivion Inc, a worldwide supplier of ingredient solutions, has introduced a new product line consisting of Empty Gelatin, HPMC, And Pullulan Capsules. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising focus on development of new products, growing preference among the general population for choosing capsules as their preferred dosage form, and increasing regulatory approvals. For instance, in July 2022, As reported by EThealthworld.com, Akums Drug & Pharmaceuticals Ltd. has been granted approval by the European Union (EU) Good Manufacturing Practice (GMP) for their manufacturing facilities producing empty hard gelatin capsules in Haridwar, India.
Surge in approval of new capsules is predicted to boost the market growth during the forecast period. Empty capsules are frequently employed for the containment of powders, medicines, and herbal substances. In comparison to tablets, capsules are more convenient to ingest. Pharmaceutical companies utilize them to formulate a wide range of therapeutic drugs. For instance, in February 2022, CapsCanada, a subsidiary of Lyfe Group, has obtained approval for a liquid-filled aspirin capsule. This product utilizes the PLxGuard drug delivery platform, designed to deliver medications within the gastrointestinal tract.
By type, gelatin capsules was the highest revenue-grossing segment in the global empty capsules market in 2023 owing to the affordability & ready availability of gelatine for production, increasing adoption of capsule formulation, surge in the protein content of gelatin capsules, growing advancements in capsule delivery technologies, and rising launch of new products. For instance, in May 2022, Lonza has broadened its Capsugel product range by introducing a white hard gelatin capsule that is free from titanium dioxide (TiO2). This move aligns with the changing preferences of its customers, who seek compliance with the new TiO2-free regulations for food products in the European Union. Additionally, non-gelatin capsules is predicted to grow at fastest CAGR during the forecast period owing to the rising demand of HPMC capsules due to their low moisture content, resistance to bacterial growth, & the absence of a need for preservatives during production and increasing adoption of vegetarian lifestyle with dietary needs.
By functionality, immediate release was the highest revenue-grossing segment in the global empty capsules market in 2023 owing to the growing demand for these capsules for manufacturing drug preparations such as antacids, antibacterial antibiotics and increasing introduction of new products. For instance, in November 2022, Lonza has introduced a novel capsule solution called Enprotect, specifically designed to enhance the delivery of acid-sensitive Active Pharmaceutical Ingredients (APIs) when ingested. This product launch has contributed to the expansion of the company's product portfolio. Additionally, sustained release is predicted to grow at fastest CAGR during the forecast period owing to the rising focus on development of advanced capsules and surge in research & development activities.
By application, cardiovascular therapy drugs was the highest revenue-grossing segment in the global empty capsules market in 2023 owing to rising prevalence of cardiovascular diseases, surge in approvals by regulatory bodies, and growing need for empty capsules to conceal the taste of cardiac therapy medications, effectively preventing patients from experiencing nausea. Additionally, dietary supplements is predicted to grow at fastest CAGR during the forecast period owing to the availability & growing demand of dietary supplements and surge in mergers & acquisitions by market players. For instance, in December 2022, Vantage Nutrition LLC, a subsidiary of the ACG Group, has acquired AquaCap, an asset of Nestle Health Science, which is based in Philadelphia. The primary objective of this acquisition is to increase Vantage Nutrition's presence and enhance its manufacturing capabilities.
By end-user, pharmaceutical companies was the highest revenue-grossing segment in the global empty capsules market in 2023 owing to surge in prevalence of various diseases, increasing focus on development of advanced capsules with superior quality & dissolution properties, growing support & incentives provided by the government for the manufacturing of various pharmaceutical products, and rising mergers & acquisitions within market players. For instance, in March 2023, VANTAGE NUTRITION, a subsidiary of ACG, has successfully acquired ComboCap, Inc. in the United States and BioCap in South Africa. This strategic move is part of their plan to broaden their technological capabilities and expand their presence in North America and worldwide. Additionally, nutraceutical industry is predicted to grow at fastest CAGR during the forecast period owing to the growing preference of nutraceuticals products by population, rising prevalence of chronic conditions such as cardiovascular disease & diabetes due to the adoption of sedentary lifestyle, and surge in demand for dietary supplements.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing preference for capsule-based nutraceutical formulations, rising prevalence of chronic diseases, surge in research & development activities, and growing launch of new products. For instance, in February 2023, Vivion Inc, a worldwide supplier of ingredient solutions, has introduced a new product line consisting of Empty Gelatin, HPMC, And Pullulan Capsules. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising focus on development of new products, growing preference among the general population for choosing capsules as their preferred dosage form, and increasing regulatory approvals. For instance, in July 2022, As reported by EThealthworld.com, Akums Drug & Pharmaceuticals Ltd. has been granted approval by the European Union (EU) Good Manufacturing Practice (GMP) for their manufacturing facilities producing empty hard gelatin capsules in Haridwar, India.
Segmentation: Empty Capsules Market Report 2023 - 2034
Empty Capsules Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- Non-Gelatin Capsules
- Gelatin Capsules
Empty Capsules Market Analysis & Forecast by Functionality 2023 - 2034 (Revenue USD Bn)
- Sustained Release
- Immediate Release
- Delayed Release
Empty Capsules Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Anti-Inflammatory Drugs
- Antibiotic & Antibacterial Drugs
- Cardiovascular Therapy Drugs
- Dietary Supplements
- Anti-Anemic Preparations (Hematinic)
- Cough & Cold Drugs
- Antacid & Anti-flatulent Preparations
- Others
Empty Capsules Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Nutraceutical Industry
- Pharmaceutical Companies
- Research Laboratories
- Cosmetic Industry
Empty Capsules Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Empty Capsules Market: Type Estimates & Trend Analysis
8. Empty Capsules Market: Functionality Estimates & Trend Analysis
9. Empty Capsules Market: Application Estimates & Trend Analysis
10. Empty Capsules Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Empty Capsules Market
13. Europe Global Empty Capsules Market
14. Asia Pacific Global Empty Capsules Market
15. Latin America Global Empty Capsules Market
16. MEA Global Empty Capsules Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Lonza Group Ltd. (Capsugel)
- ACG Worldwide
- Roxlor LLC
- CapsCanada Corporation
- Suheung Co. Ltd
- Medi-Caps Ltd.
- Bright Pharma Caps Inc.
- Mitsubishi Chemical Holdings Corporation (Qualicaps Inc.)
- Sunil Healthcare Ltd.
- Snail Pharma Industry Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 3.46 Billion |
| Forecasted Market Value ( USD | $ 9.72 Billion |
| Compound Annual Growth Rate | 9.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
